← Back to Search

Other

Tarsus Patch Group for Lagophthalmos

N/A
Waitlist Available
Led By Angeline M Nguyen, MD
Research Sponsored by Angeline Nguyen
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the parental survey will be administered by phone on day 4, which is after the last day the subject wears the tarsus patch at home. the survey should take about 3 minutes per person.
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new patch called the Nictavi Tarsus Patch, which helps keep the eyelids closed during sleep. It is designed for children and adolescents who have trouble closing their eyelids completely, a condition known as lagophthalmos. The patch aims to be more comfortable than existing methods, making it easier for patients to use consistently and protect their eyes from damage.

Eligible Conditions
  • Lagophthalmos

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~these surveys will be administered by phone on day 4, which is after the last day the subject wears the tarsus patch at home. the survey should take about 3 minutes per person.
This trial's timeline: 3 weeks for screening, Varies for treatment, and these surveys will be administered by phone on day 4, which is after the last day the subject wears the tarsus patch at home. the survey should take about 3 minutes per person. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Lagophthalmos in "eyes closed" position
Secondary study objectives
Interpalpebral fissure distance in upgaze
Parental and subjects' subjective experience using the Tarsus Patch
Parental report of safety while using the Tarsus Patch

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Tarsus Patch GroupExperimental Treatment1 Intervention
All subjects will receive the Tarsus Patch to be worn and evaluated by the investigator in the clinic and to also be worn at home for 3 nights.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tarsus Patch
2022
N/A
~20

Find a Location

Who is running the clinical trial?

Angeline NguyenLead Sponsor
Angeline M Nguyen, MDPrincipal InvestigatorChildren's Hospital Los Angeles
~6 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top